76.56 USD
↗ 2.76 (3.74%)AT CLOSE (11:59 AM EDT)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
76.32
↘ 0.24 (0.31%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
76.32
↘ 0.24 (0.31%)
Market: CLOSED
Moderna, Inc. Common Stock (MRNA) is currently trading at $76.55. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Furthermore, MRNA is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Jul 9, 2026.
Open?$73.80
High?$76.84
Low?$73.14
Prev. Close?$73.80
Volume?4.4M
Avg. Volume?8.5M
VWAP?$75.76
Rel. Volume?0.52x
Bid / Ask
Bid?$75.86 × 100
Ask?$76.62 × 100
Spread?$0.76
Midpoint?$76.24
Valuation & Ratios
Market Cap?30.4B
Shares Out?396.8M
Float?361.1M
Float %?91.0%
P/E Ratio?N/A
P/B Ratio?4.10
EPS?-$8.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Themes
Employees
4.7K
Market Cap
29.3B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?97
Momentum?35
Short Sent.?19
Piotroski F-Score?1/9Weak
Altman Z-Score?4.75Safe
Confidence?58%Low
Short InterestVery High
Short % of Float?16.25%High
Short Interest?58.7M
Days to Cover?10.5
Free Float361.1M
Avg Daily Volume5.6M
Settlement Date2026-06-15
Financial Health
Current Ratio?2.41Strong
Quick Ratio?2.35Strong
Cash Ratio?0.80Adequate
Debt/Equity?0.08Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.10FAIR▾
Peers70
S&P44
P/S?13.65HIGH▾
Peers55
S&P3
P/FCF?N/A▾
EV/EBITDA?-9.2CHEAP▾
Peers100
S&P97
EV/Sales?13.07HIGH▾
Peers55
S&P6
Returns & Efficiency
ROE?-43.1%WEAK▾
Peers11
S&P3
ROA?-27.8%WEAK▾
Peers13
S&P3
Cash Flow & Enterprise
FCF?$-1603000000
Enterprise Value?$29.1B
Fundamentals ratios updated end of day